Literature DB >> 6174704

Hypothalamic-pituitary function in myotonic dystrophy.

C Mahler, G Parizel.   

Abstract

Function of the hypothalamic-pituitary axis was investigated in seven patients with myotonic dystrophy (MD). HGH and ACTH secretion were normal. TSH response to TRH was impaired in about half the cases, without concomitant thyroid dysfunction. LH and FSH levels were often elevated, with inconsistent response to LH-RH stimulation, Gonadotrophin disturbances in MD have previously been attributed to a primary gonadal lesion, characteristically seen in this disease. High prolactin levels in six of our seven patients however suggest that gonadal failure may be also be due to hyperprolactinemia through the direct anti-gonadal effect of prolactin and its interference with hypothalamic-pituitary regulation of gonadotrophin secretion.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174704     DOI: 10.1007/BF00313396

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  Prolactin-screening tumors and hypogonadism in 22 men.

Authors:  J N Carter; J E Tyson; G Tolis; S Van Vliet; C Faiman; H G Friesen
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

2.  Myotonia dystrophica: Studies on gonadal function using luteinizing hormone-releasing hormone (LRH).

Authors:  J Sagel; L A Distiller; J E Morley; H Isaacs; G Kay; A Van Der Walt
Journal:  J Clin Endocrinol Metab       Date:  1975-06       Impact factor: 5.958

3.  Pituitary-gonadal function in male patients with myotonic dystrophy- serum luteinizing hormone, follicle stimulating hormone and testosterone levels and histological dmaage of the testis.

Authors:  R Takeda; M Ueda
Journal:  Acta Endocrinol (Copenh)       Date:  1977-02

4.  Clinical and endocrine features of hyperprolactinaemic amenorrhoea.

Authors:  H S Jacobs; S Franks; M A Murray; M G Hull; S J Steele; J D Nabarro
Journal:  Clin Endocrinol (Oxf)       Date:  1976-09       Impact factor: 3.478

5.  Hyperprolactinemic anovulatory syndrome.

Authors:  H G Bohnet; H G Dahlén; W Wuttke; H P Schneider
Journal:  J Clin Endocrinol Metab       Date:  1976-01       Impact factor: 5.958

6.  [Endocrinological studies on myotonic dystrophy--insulin and HGH responses in myotonic dystrophy].

Authors:  M Yamamoto; S Kito; N Fujimori; K Kosaka
Journal:  Rinsho Shinkeigaku       Date:  1974-05

7.  Hypothalamic-pituitary function in diverse hyperprolactinemic states.

Authors:  R M Boyar; S Kapen; J W Finkelstein; M Perlow; J F Sassin; D K Fukushima; E D Weitzman; L Hellman
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

8.  Hypothalamic-pituitary-gonadal function in patients with myotonic dystrophy.

Authors:  F Febres; H Scaglia; R Lisker; J Espinosa; T Morato; M Shkurovich; G Përez-Palacios
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

9.  Prevalence and presentation of hyperprolactinaemia in patients with "functionless" pituitary tumours.

Authors:  S Franks; J D Nabarro
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

10.  Plasma androgens in women with hyperprolactinaemic amenorrhoea.

Authors:  F Bassi; G Giusti; L Borsi; S Cattaneo; P Giannotti; G Forti; M Pazzagli; C Vigiani; M Serio
Journal:  Clin Endocrinol (Oxf)       Date:  1977-01       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.